Skip to main content

Table 8 Univariate and multivariate analysis of prognostic indicators on cancer-specific survival for stage III colorectal cancer patients

From: Preoperative serum carcinoembryonic antigen, albumin and age are supplementary to UICC staging systems in predicting survival for colorectal cancer patients undergoing surgical treatment

Parameters Number Univariate analysis Multivariate analysis
   Hazard ratio (95% CI) P value Hazard ratio (95% CI) P value
Age (≥65/<65)years 189/193 1.33(0.90–1.96) 0.148 - -
Sex (Male/Female) 198/184 0.74(0.52–1.05) 0.092 - -
Site (Colon/Rectum) 263/119 0.96(0.66–1.40) 0.818 - -
Tumor size (≥5/<5)cm 170/212 1.24(0.86–1.78) 0.252 - -
BMIa (≥24/≥18.5–24/<18.5) 123/150/109 1.01(0.63–1.61) 0.984 - -
Albumin (<3.5/≥3.5)gm/dl 110/272 1.35(0.85–2.15) 0.207 - -
Histology (PD/MD/WDb) 62/278/42 2.11(0.91–4.92) 0.083 - -
CEAc (≥5/<5) ng/ml 193/189 1.74(1.22–2.50) 0.002 1.74(1.22–2.50) 0.002
  1. aBody mass index
  2. bPoorly differentiated; Moderately differentiated; Well differentiated
  3. cCarcinoembrynic antigen